(Post-pandemic Era)-Global Intravenous (IV) Ibuprofen Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
- Report Code : XYZ2131729
- Published On: Nov, 2020
- Category : Medical Devices
- Pages : 106
-
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Research team published a report for global Intravenous (IV) Ibuprofen market in this environment.
In terms of revenue, this research report indicated that the global Intravenous (IV) Ibuprofen market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Intravenous (IV) Ibuprofen industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Cumberland Pharmaceuticals aims at producing XX Intravenous (IV) Ibuprofen in 2020, with XX % production to take place in global market, Alveda Pharmaceuticals accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Intravenous (IV) Ibuprofen Market Include by
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Intravenous (IV) Ibuprofen Market
Cumberland Pharmaceuticals
Alveda Pharmaceuticals
CSL Limited
Sandor Medicaids
PT. Soho Industri Pharmasi
Germin MED
Grifols
Harbin Gloria Pharmaceuticals
Al Nabeel International
Laboratorios Valmorca
Major Type of Intravenous (IV) Ibuprofen Covered in report:
Pain/Inflammatory
Fever
Application Segments Covered in report
Pediatrics
Adults
Application 3
For any other requirements, please feel free to contact us and we will provide you customized report.
-
With tables and figures helping analyze worldwide (Post pandemic Era) Global Intravenous (IV) Ibuprofen market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Global Intravenous (IV) Ibuprofen Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope1.1 Product Details and Introduction
1.1.1 Pain/Inflammatory -Product Introduction and Major Manufacturers
1.1.2 Fever -Product Introduction and Major Manufacturers1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Intravenous (IV) Ibuprofen Market Assessment, by Segmentation2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis3.1 China Intravenous (IV) Ibuprofen Market
3.1.1 Top Companies leading Intravenous (IV) Ibuprofen Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Intravenous (IV) Ibuprofen Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)3.2 EU Intravenous (IV) Ibuprofen Market
3.2.1 Top Companies leading Intravenous (IV) Ibuprofen Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Intravenous (IV) Ibuprofen Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)3.3 USA Intravenous (IV) Ibuprofen Market
3.3.1 Top Companies leading Intravenous (IV) Ibuprofen Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Intravenous (IV) Ibuprofen Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)3.4 Japan Intravenous (IV) Ibuprofen Market
3.4.1 Top Companies leading Intravenous (IV) Ibuprofen Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Intravenous (IV) Ibuprofen Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)3.5 India Intravenous (IV) Ibuprofen Market
3.5.1 Top Companies leading Intravenous (IV) Ibuprofen Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Intravenous (IV) Ibuprofen Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)3.6 Southeast Asia Intravenous (IV) Ibuprofen Market
3.6.1 Top Companies leading Intravenous (IV) Ibuprofen Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Intravenous (IV) Ibuprofen Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Intravenous (IV) Ibuprofen Market
3.7.1 Top Companies leading Intravenous (IV) Ibuprofen Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Intravenous (IV) Ibuprofen Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)4.1 Intravenous (IV) Ibuprofen Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream4.2 COVID-19 Impact on Intravenous (IV) Ibuprofen Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)5.1 Global Intravenous (IV) Ibuprofen Sales and Growth Rate (2021-2026)
5.2 Global Intravenous (IV) Ibuprofen Sales Value and Growth Rate (2021-2026)
6 Intravenous (IV) Ibuprofen Competitive Analysis6.1 Cumberland Pharmaceuticals
6.1.1 Cumberland Pharmaceuticals Company Profiles
6.1.2 Cumberland Pharmaceuticals Product Introduction
6.1.3 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Production, Revenue (2015-2020)
6.1.4 SWOT Analysis6.2 Alveda Pharmaceuticals
6.2.1 Alveda Pharmaceuticals Company Profiles
6.2.2 Alveda Pharmaceuticals Product Introduction
6.2.3 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Production, Revenue (2015-2020)
6.2.4 SWOT Analysis6.3 CSL Limited
6.3.1 CSL Limited Company Profiles
6.3.2 CSL Limited Product Introduction
6.3.3 CSL Limited Intravenous (IV) Ibuprofen Production, Revenue (2015-2020)
6.3.4 SWOT Analysis6.4 Sandor Medicaids
6.4.1 Sandor Medicaids Company Profiles
6.4.2 Sandor Medicaids Product Introduction
6.4.3 Sandor Medicaids Intravenous (IV) Ibuprofen Production, Revenue (2015-2020)
6.4.4 SWOT Analysis6.5 PT. Soho Industri Pharmasi
6.5.1 PT. Soho Industri Pharmasi Company Profiles
6.5.2 PT. Soho Industri Pharmasi Product Introduction
6.5.3 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Production, Revenue (2015-2020)
6.5.4 SWOT Analysis6.6 Germin MED
6.6.1 Germin MED Company Profiles
6.6.2 Germin MED Product Introduction
6.6.3 Germin MED Intravenous (IV) Ibuprofen Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Grifols
6.7.1 Grifols Company Profiles
6.7.2 Grifols Product Introduction
6.7.3 Grifols Intravenous (IV) Ibuprofen Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Harbin Gloria Pharmaceuticals
6.8.1 Harbin Gloria Pharmaceuticals Company Profiles
6.8.2 Harbin Gloria Pharmaceuticals Product Introduction
6.8.3 Harbin Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 Al Nabeel International
6.9.1 Al Nabeel International Company Profiles
6.9.2 Al Nabeel International Product Introduction
6.9.3 Al Nabeel International Intravenous (IV) Ibuprofen Production, Revenue (2015-2020)
6.9.4 SWOT Analysis6.10 Laboratorios Valmorca
6.10.1 Laboratorios Valmorca Company Profiles
6.10.2 Laboratorios Valmorca Product Introduction
6.10.3 Laboratorios Valmorca Intravenous (IV) Ibuprofen Production, Revenue (2015-2020)
6.10.4 SWOT Analysis
7 Conclusion
-
The (Post pandemic Era) Global Intravenous (IV) Ibuprofen Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
New players are entering the (Post pandemic Era) Global Intravenous (IV) Ibuprofen Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
From 2024 to 2029, the (Post pandemic Era) Global Intravenous (IV) Ibuprofen Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.
The convergence of various vital triggers, including a major slowdown in Western economies, and some critical points in globalization, leads to the transformation of business in the (Post pandemic Era) Global Intravenous (IV) Ibuprofen Market across the extensive corporate landscape.
In this highly competitive and rapidly evolving (Post pandemic Era) Global Intravenous (IV) Ibuprofen Industry, top strategic priorities such as innovation, diversification, and M&A would remain consistent.
